Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Elexir Pharma Capital AB
AB
Active
Org 5565873659
Kornhamnstorg 61, 111 27
Stockholm
Other financial service activities, except insurance and pension funding n.e.c.
·
NACE 6499
Est. 2000 · 26 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Elexir Pharma Capital AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
0
0
0
0
0
Staff expenses
−240
—
—
—
—
EBITDA
−399
−295
−274
−284
−260
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−399
−295
−274
−284
−260
Net financials
5 611
6 015
5 029
3 000
5 000
Profit before tax
5 212
5 720
4 754
2 716
4 740
Tax
−0
−0
−0
−0
−0
Net profit
5 212
5 720
4 754
2 716
4 740
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
11 708
12 140
10 665
8 520
9 724
Equity
9 887
10 675
9 455
7 550
8 834
Long-term debt
0
0
0
0
0
Short-term debt
161
45
30
30
210
Total debt
161
45
30
30
210
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
84,4 %
This company
38,2 %
Market median
This company
Market median
121% above market
2021
2025
Return on equity
52,7 %
This company
18,4 %
Market median
This company
Market median
186% above market
2021
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,18×
This company
0,62×
Market median
This company
Market median
71% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Elexir Pharma Capital AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
